Cabozantinib impurity DX2

Product Name: Cabozantinib impurity DX2
CAS No.: 1628530-38-0
Chemical Name: Cabozantinib impurity DX2
Synonyms: Cabozantinib Impurity 78;Cabozantinib impurity 65;Cabozantinib impurity DX2;Cabozantinib Metabolite M9;Tributyl Acetylcitrate Impurity 1 (Tributyl Acetylcitrate EP Impurity A);N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1,1-dicarboxamide;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-2-hydroxyphenyl)-1,1-cyclopropanedicarboxamide;1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-2-hydroxyphenyl)-;N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1,1-dicarboxamide? (Cabozantinib Impurity）
CBNumber: CB55590037
Molecular Formula: C28H24FN3O6
Formula Weight: 517.51
MOL File: 1628530-38-0.mol

More

Less

Cabozantinib impurity DX2 Property

Boiling point:: 781.8±60.0 °C(Predicted)
Density: 1.447±0.06 g/cm3(Predicted)
pka: 8.42±0.40(Predicted)

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

Cabozantinib impurity DX2 Chemical Properties,Usage,Production

Uses

2-??Hydroxy Cabozantinib is a metabolite of cabozantinib (CAS# 849217-68-1), which is a tyrosine kinase inhibitor and an anticancer drug used in the treatment of thyroid cancer, renal cell carcinoma and hepatocellular carcinoma.

Cabozantinib impurity DX2 Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Cabozantinib impurity DX2 Suppliers

China 14 India 1 Global 15

1628530-38-0, Cabozantinib impurity DX2Related Search:

4-Aminoveratrole Cabozantinib Impurity 5 N-(4-fluorophenyl)-N-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide 4-chloro-6,7-dimethoxyquinoline Cabozantinib Impurity EXA 1-(4-Fluorophenylcarbamoyl)cyclopropanecarboxylic acid Cyclopropanecarboxylic acid, 1-[[[4-[[7-methoxy-6-(sulfooxy)-4-quinolinyl]oxy]phenyl]amino]carbonyl]- 1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenyl- Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)- Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]- Cabozantinib Malate 1,1-Cyclopropanedicarboxamide, N,N'-bis[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]- Cyclopropanecarboxylic acid, 1-[[(2-fluorophenyl)amino]carbonyl]- Cabozantinib Impurity DM 1,3-Dioxane-4,6-dione, 5-[[(3,4-diMethoxyphenyl)aMino]Methylene]-2,2-diMethyl- N,N'-Bis(4-hydroxyphenyl)hydrazine N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide Cabozantinib impurity 1DYH

N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-2-hydroxyphenyl)-1,1-cyclopropanedicarboxamide

Cabozantinib impurity DX2

Cabozantinib impurity 65

1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-2-hydroxyphenyl)-

N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1,1-dicarboxamide

Cabozantinib Metabolite M9

Cabozantinib Impurity 78

Tributyl Acetylcitrate Impurity 1 (Tributyl Acetylcitrate EP Impurity A)

N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1,1-dicarboxamide? (Cabozantinib Impurity）

1628530-38-0